Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for DASATINIB

Ingredient

DASATINIB

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TARO-DASATINIB	50MG	TABLET	Resolved	2024-10-17	2025-01-27	240463
TARO-DASATINIB	50MG	TABLET	Resolved	2026-03-09	2026-03-16	280037
TARO-DASATINIB	70MG	TABLET	Resolved	2022-11-04	2023-02-01	173716
TARO-DASATINIB	70MG	TABLET	Resolved	2026-03-09	2026-03-16	280040
TARO-DASATINIB	80MG	TABLET	Resolved	2022-11-04	2023-02-01	173719
TARO-DASATINIB	80MG	TABLET	Resolved	2026-03-09	2026-03-16	280043
TARO-DASATINIB	100MG	TABLET	Resolved	2022-11-04	2023-02-01	173724
TARO-DASATINIB	100MG	TABLET	Resolved	2025-11-13	2026-03-02	271667
TARO-DASATINIB	140MG	TABLET	Resolved	2022-11-04	2023-02-01	173727
TARO-DASATINIB	140MG	TABLET	Resolved	2026-03-09	2026-03-16	280046

Showing 21 to 30 of 31

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0